<!– Click –> <!– –>

<!– Click –> <!– –>

<!– Click –> <!– –>

<!– Click –> <!– –>

<!– Click –>

The marijuana stock market has seen quite the amount of publicity over the course of the past few years. With so much changing including laws and the public perception of the substance, it seems only fitting that companies would be working hard to meet these future goals. The companies at the top of the industry continue to be those who grow the substance in its raw form, and they are working to produce large quantities of cannabis. Although some have stated that we are seeing an undersupply, it looks as though there are many companies that are working to solve this.

Nabis Holdings (INNPF/NAB) is one of the leading investment issuers working out of the Canadian space. Although they are headquartered in Canada, many of their operations have since been seen in the U.S. market. The company has been working throughout the various facets of the industry to continue providing investors with the best situation possible. For those who don’t know, the co-founders of Nabis Holdings previously led MPX Bioceutical to the largest cannabis takeover in the U.S. marijuana space to date. With sight set high on revenue generation and growth in the vertical aspect of the industry, Nabis Holdings continues to be a promising company to keep an eye on.

The company recently announced that they have completed their investment in both Battle Creek and Constantine, Michigan, for the provisioning centers that they have located there. The goal is to target the Michigan cannabis market which has become one of the fastest booming markets in the nation despite it only being around for a short period of time. Additionally, they have also stated that they are working to complete their other three provisioning centers in the state which should be announced within the coming weeks.

Once they are finished with these acquisitions, they should have as many as seven provisioning centers in the state with plans to add as many as ten to fifteen more. This should help them on their way to moving deeper into the U.S. cannabis market one step at a time. Shay Shnet, CEO of Nabis Holdings stated that “we continue to cement our foundation in Michigan with the completion of our investments in the Battle Creek and Constantine provisioning centers. With additional provisioning centers, we believe Nabis is well positioned in the largest medical licensing cannabis market in the U.S.”

Cara Therapeutics (CARA) is a company that operates in the ancillary market for cannabis. The company is a producer of pharmaceuticals that has seen a large amount of success in recent times. With their drugs receiving approvals from the FDA in the U.S., they definitely look like they are on the right track.

One of the things to keep in mind, however, is that Cara has been known to be quite volatile along with many other stocks in the industry. This, however, has its positives and negatives. The best advice here is to simply do the research and know what investing style fits best.

Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Nabis Holdings (OTC:INNPF) (CSE:NAB), Midam has been paid $250,000 by Nabis Holdings (OTC:INNPF) (CSE:NAB) for a period from January 22, 2019 to April 22, 2019. We may buy or sell additional shares of (OTC:INNPF) (CSE:NAB) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Nabis Holdings (OTC:INNPF) (CSE:NAB).

The Green Organic Dutchman (TGODF) (TGOD) is one of the key marijuana growers in the Canadian industry. TGOD was able to close over 20% higher in the past few days which is quite a dramatic increase given the amount of bearish sentiment filling the market in the past few months.

The Green Organic Dutchman is however not that small of a company considering their market cap of around $820 million by end of closing on January 11th. As one of the major producers of cannabis, they have been able to set the bar for growing high quality, organic marijuana.

CV Sciences (CVSI) is a primary producer of cannabidiol-based pharmaceuticals. The company has been able to work on new medicines using natural components of the cannabis plant. Cannabis has a large number of cannabinoids which have not been researched extensively at this point but are showing a large amount of promise for treating and curing a wide variety of ailments.

The company has seen their shares up by around 14.4% YTD which is also quite sizable. CV Sciences remains an interesting pharmaceutical company for investors looking for an alternative exposure to marijuana stocks.

Cara Therapeutics (CARA) should be a familiar name to anyone involved in the marijuana industry. Cara is also a producer of biotech using cannabinoids to make their products. The company is up over 25% in the past month or so, showing investors a new side of trust for biotech-based cannabis companies.

Cara is considered to be one of the key players in this side of the industry and should give investors a large amount of exposure to biotech. Cara is however traded quite speculatively which makes them a topsy turvy choice for some investors.

The speculative aspect of their business has also helped to bring some investors in, but additionally, they have been able to stabilize their pricing to some extent. Marijuana as a whole has remained highly speculative due to the nature of the market and mainly, the infancy of the industry overall. As we move throughout the next year, the hopes are that this will begin to settle down allowing companies to reach their true intrinsic values.

Marijuana stocks remain some of the most interesting investments in the whole of the stock market. Many investors were turned off by the end of the year performance during 2018, but it appears as though the beginning of the new year has left a solid impression on investors. With so many gains occurring throughout the first two weeks of the year, the future of marijuana remains incredibly bright for those willing and brave enough to make the entrance into it.

Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and The Green Organic Dutchman, Midam is being paid $20,000 per month for a period beginning July 30, 2018, and ending July 30, 2019. We may buy or sell additional shares of (TGODF/TGOD) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about The Green Organic Dutchman. The principles of MAPH participated in the IPO for The Green Organic Dutchman Holdings, Ltd. (TGOD) & own a collective 193,797 free trading shares & 9,725 warrants. The principals of MAPH intend to sell their positions in (TGOD) for profit. MAPH nor any of its principals have been compensated for any material related to (TGOD). As of November 13, 2018 a member of MAPH Enterprises LLC holds freely trading 231,300 shares and 150,000 warrants of The Green Organic Dutchman (TGODF) purchased in the open market. These may be sold at any point. This disclaimer will be updated at such time.